Pharming News and Activities

View the org chart displaying its 35 main executives

Most searched biographies at Pharming

• Fabrice Chouraqui, Executive Director and Chief Executive Officer
• Jabine Van Der Meijs, Director
• Richard Peters, Chairman of the Board

Popular executive movements at Pharming

• Michael Levitan who was Vice President, Investor Relations and Corporate Communications, becomes Vice President, Investor Relations and Capital Markets  (posted on June 19 2026).
• Leverne Marsh has joined the company as President, Chief Commercial Officer  (posted on February 5 2026).

Create your alert
to follow the executive moves at Pharming.

Pharming has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Pharming

• Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
• Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
• Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
• Pharming Group announces results of 2026 Annual General Meeting of Shareholders
• Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
• Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
• Pharming Group to report first quarter 2026 financial results and provide business update on May 7
• Pharming Group announces the 2026 Annual General Meeting of Shareholders
• Pharming Group to participate in April investor conferences
• Pharming Group announces the filing of its 2025 Annual Report and Form 20-F
• View more press releases Close

Social media about Pharming

• Pharming on Wikipedia, Google News & Yahoo Finance
• Pharming on LinkedIn, X (Twitter) & YouTube